Home / Recalls / Johnson Matthey Inc. / D-1882-2019

D-1882-2019 Class II Terminated

Recalled by Johnson Matthey Inc. — West Deptford, NJ

Recall Details

Product Type
Drugs
Report Date
October 2, 2019
Initiation Date
August 29, 2019
Termination Date
January 21, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
316703.32

Product Description

Oxaliplatin Active Pharmaceutical Ingredient, Johnson Matthey Pharmaceutical Materials 2003 Nolte Drive, West Deptford, NJ 08066-1742 (856) 384-7001, NDC 49821-0075-XX

Reason for Recall

cGMP Deviations: Potential glass contamination

Distribution Pattern

Nationwide within the United States

Code Information

Lot #: B0126-170701; B0126-170802; Exp. Sep 2022; B0126-180401, Exp. May 2023; B0126-180702, B0126-180803, Exp. Oct 2023

Other recalls by Johnson Matthey Inc.

  • D-1881-2019 Class II — Cisplatin Active Pharmaceutical Ingredient, Johnson Matthey Pharmaceutical Mater (August 29, 2019)
  • D-1880-2019 Class II — Fentanyl Citrate Active Pharmaceutical Ingredient, Johnson Matthey Pharmaceutica (August 29, 2019)
  • D-1252-2019 Class III — Remifentanil HCl active pharmaceutical ingredient (API) for manufacturing, proce (April 2, 2019)
  • D-1077-2019 Class II — Morphine Sulfate USP Milled, Active Pharmaceutical Ingredient, Rx only, Johnson (March 5, 2018)